Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

November 2001

Volume 944 BIOARTIFICIAL ORGANS III: TISSUE SOURCING, IMMUNOISOLATION, AND CLINICAL TRIALS

Pages xi–xi, 1–490

  1. Frontmatter

    1. Top of page
    2. Frontmatter
    3. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part I. Introduction and Historical Perspective
    4. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part II. Tissue Sourcing
    5. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    6. Article: Part III. Immunoisolation and Encapsulation BIOARTIFICIAL ORGANS III: TISSUE SOURCING, IMMUNOISOLATION, AND CLINICAL TRIALS
    7. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    8. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IV. Biomaterial Purification and Compatability
    9. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part V. Islet and Bioartificial Pancreas
    10. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VI. Bioartificial Kidney and Liver
    11. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VII. Blood Substitutes and Endocrinology: Clinical Trials
    12. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VIII. Tissue Engineering
    13. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IX. Perspectives
    1. Acknowledgments (page xi)

      David Hunkeler

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03817.x

  2. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part I. Introduction and Historical Perspective

    1. Top of page
    2. Frontmatter
    3. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part I. Introduction and Historical Perspective
    4. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part II. Tissue Sourcing
    5. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    6. Article: Part III. Immunoisolation and Encapsulation BIOARTIFICIAL ORGANS III: TISSUE SOURCING, IMMUNOISOLATION, AND CLINICAL TRIALS
    7. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    8. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IV. Biomaterial Purification and Compatability
    9. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part V. Islet and Bioartificial Pancreas
    10. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VI. Bioartificial Kidney and Liver
    11. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VII. Blood Substitutes and Endocrinology: Clinical Trials
    12. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VIII. Tissue Engineering
    13. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IX. Perspectives
    1. Bioartificial Organs: Glossary of Terms (pages 7–17)

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03819.x

  3. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part II. Tissue Sourcing

    1. Top of page
    2. Frontmatter
    3. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part I. Introduction and Historical Perspective
    4. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part II. Tissue Sourcing
    5. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    6. Article: Part III. Immunoisolation and Encapsulation BIOARTIFICIAL ORGANS III: TISSUE SOURCING, IMMUNOISOLATION, AND CLINICAL TRIALS
    7. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    8. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IV. Biomaterial Purification and Compatability
    9. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part V. Islet and Bioartificial Pancreas
    10. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VI. Bioartificial Kidney and Liver
    11. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VII. Blood Substitutes and Endocrinology: Clinical Trials
    12. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VIII. Tissue Engineering
    13. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IX. Perspectives
    1. In Vitro Maturation of Neonatal Porcine Islets : A Novel Model for the Study of Islet Development and Xenotransplantation (pages 47–61)

      TANYA M. BINETTE, JANNETTE M. DUFOUR and GREGORY S. KORBUTT

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03822.x

  4. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation

    1. Top of page
    2. Frontmatter
    3. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part I. Introduction and Historical Perspective
    4. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part II. Tissue Sourcing
    5. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    6. Article: Part III. Immunoisolation and Encapsulation BIOARTIFICIAL ORGANS III: TISSUE SOURCING, IMMUNOISOLATION, AND CLINICAL TRIALS
    7. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    8. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IV. Biomaterial Purification and Compatability
    9. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part V. Islet and Bioartificial Pancreas
    10. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VI. Bioartificial Kidney and Liver
    11. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VII. Blood Substitutes and Endocrinology: Clinical Trials
    12. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VIII. Tissue Engineering
    13. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IX. Perspectives
    1. Hydrogels for Biomedical Applications (pages 62–73)

      ALLAN S. HOFFMAN

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03823.x

    2. Non-Invasive Monitoring of a Bioartificial Pancreas in Vitro and in Vivo (pages 83–95)

      IOANNIS CONSTANTINIDIS, ROBERT LONG JR., COLIN WEBER, SUSAN SAFLEY and ATHANASSIOS SAMBANIS

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03825.x

    3. NMR Spectroscopy in β Cell Engineering and Islet Transplantation (pages 96–119)

      KLEARCHOS K. PAPAS, CLARK K. COLTON, JOHN S. GOUNARIDES, ERIC S. ROOS, MARY ANN C. JAREMA, MICHAEL J. SHAPIRO, LEO L. CHENG, GARY W. CLINE, GERALD I. SHULMAN, HAIYAN WU, SUSAN BONNER-WEIR and GORDON C. WEIR

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03826.x

  5. Article: Part III. Immunoisolation and Encapsulation BIOARTIFICIAL ORGANS III: TISSUE SOURCING, IMMUNOISOLATION, AND CLINICAL TRIALS

    1. Top of page
    2. Frontmatter
    3. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part I. Introduction and Historical Perspective
    4. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part II. Tissue Sourcing
    5. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    6. Article: Part III. Immunoisolation and Encapsulation BIOARTIFICIAL ORGANS III: TISSUE SOURCING, IMMUNOISOLATION, AND CLINICAL TRIALS
    7. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    8. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IV. Biomaterial Purification and Compatability
    9. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part V. Islet and Bioartificial Pancreas
    10. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VI. Bioartificial Kidney and Liver
    11. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VII. Blood Substitutes and Endocrinology: Clinical Trials
    12. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VIII. Tissue Engineering
    13. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IX. Perspectives
  6. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation

    1. Top of page
    2. Frontmatter
    3. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part I. Introduction and Historical Perspective
    4. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part II. Tissue Sourcing
    5. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    6. Article: Part III. Immunoisolation and Encapsulation BIOARTIFICIAL ORGANS III: TISSUE SOURCING, IMMUNOISOLATION, AND CLINICAL TRIALS
    7. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    8. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IV. Biomaterial Purification and Compatability
    9. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part V. Islet and Bioartificial Pancreas
    10. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VI. Bioartificial Kidney and Liver
    11. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VII. Blood Substitutes and Endocrinology: Clinical Trials
    12. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VIII. Tissue Engineering
    13. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IX. Perspectives
    1. Mass Production of Embryoid Bodies in Microbeads (pages 135–143)

      JOSEF P. MAGYAR, MOHAMED NEMIR, ELISABETH EHLER, NICOLAI SUTER, JEAN-CLAUDE PERRIARD and HANS M. EPPENBERGER

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03828.x

    2. Pectin-Based Microspheres : A Preformulatory Study (pages 160–179)

      ELISABETTA ESPOSITO, RITA CORTESI, GIOVANNI LUCA and CLAUDIO NASTRUZZI

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03830.x

    3. Approaches to Development of Microencapsulated Form of the Live Measles Vaccine (pages 180–186)

      E. A. NECHAEVA, N. VARAKSIN, T. RYABICHEVA, M. SMOLINA, T. KOLOKOLTSOVA, A. VILESOV, N. AKSENOVA, R. STANKEVICH and R. ISIDOROV

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03831.x

  7. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IV. Biomaterial Purification and Compatability

    1. Top of page
    2. Frontmatter
    3. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part I. Introduction and Historical Perspective
    4. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part II. Tissue Sourcing
    5. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    6. Article: Part III. Immunoisolation and Encapsulation BIOARTIFICIAL ORGANS III: TISSUE SOURCING, IMMUNOISOLATION, AND CLINICAL TRIALS
    7. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    8. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IV. Biomaterial Purification and Compatability
    9. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part V. Islet and Bioartificial Pancreas
    10. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VI. Bioartificial Kidney and Liver
    11. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VII. Blood Substitutes and Endocrinology: Clinical Trials
    12. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VIII. Tissue Engineering
    13. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IX. Perspectives
    1. Purification of Polymeric Biomaterials (pages 187–198)

      CHRISTINE WANDREY and DIANELYS SAINZ VIDAL

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03832.x

    2. A Novel Class of Amitogenic Alginate Microcapsules for Long-Term Immunoisolated Transplantation (pages 199–215)

      ULRICH ZIMMERMANN, FRANK THÜRMER, ANETTE JORK, MEIKE WEBER, SASKIA MIMIETZ, MARKUS HILLGÄRTNER, FRANK BRUNNENMEIER, HEIKO ZIMMERMANN, INES WESTPHAL, GÜNTER FUHR, ULRIKE NÖTH, AXEL HAASE, ANDRE STEINERT and CHRISTIAN HENDRICH

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03833.x

    3. Transplantation of Alginate Microcapsules with Proliferating Cells in Mice : Capsular Overgrowth and Survival of Encapsulated Cells of Mice and Human Origin (pages 216–225)

      ANNE MARI ROKSTAD, BÅRD KULSENG, BERIT L. STRAND, GUDMUND SKJÅK-BRÆK and TERJE ESPEVIK

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03834.x

  8. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part V. Islet and Bioartificial Pancreas

    1. Top of page
    2. Frontmatter
    3. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part I. Introduction and Historical Perspective
    4. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part II. Tissue Sourcing
    5. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    6. Article: Part III. Immunoisolation and Encapsulation BIOARTIFICIAL ORGANS III: TISSUE SOURCING, IMMUNOISOLATION, AND CLINICAL TRIALS
    7. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    8. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IV. Biomaterial Purification and Compatability
    9. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part V. Islet and Bioartificial Pancreas
    10. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VI. Bioartificial Kidney and Liver
    11. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VII. Blood Substitutes and Endocrinology: Clinical Trials
    12. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VIII. Tissue Engineering
    13. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IX. Perspectives
    1. Cellular Support Systems for Alginate Microcapsules Containing Islets, as Composite Bioartificial Pancreas (pages 240–252)

      RICCARDO CALAFIORE, GIOVANNI LUCA, MARIO CALVITTI, LUCA M. NERI, GIUSEPPE BASTA, SILVANO CAPITANI, ENNIO BECCHETTI and PAOLO BRUNETTI

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03836.x

    2. Preclinical Development of the Islet Sheet (pages 252–266)

      RICHARD STORRS, RANDY DORIAN, SCOTT R. KING, JONATHAN LAKEY and HORACIO RILO

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03837.x

    3. Engineering Tolerance into Transplanted β Cell Lines (pages 267–270)

      BERNARD THORENS, PHILIPPE DUPRAZ and SANDRA COTTET

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03838.x

    4. In Vitro Test of New Biomaterials for the Development of a Bioartificial Pancreas (pages 271–276)

      N. LEMBERT, P. PETERSEN, J. WESCHE, P. ZSCHOCKE, A. ENDERLE, M. DOSER, H. PLANCK, H. D. BECKER and H.P. T. AMMON

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03839.x

    5. Newly Developed Aminopropyl-Silicate Immunoisolation Membrane for a Microcapsule-Shaped Bioartificial Pancreas (pages 277–283)

      SHINJI SAKAI, TSUTOMU ONO, HIROYUKI IJIMA and KOEI KAWAKAMI

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03840.x

  9. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VI. Bioartificial Kidney and Liver

    1. Top of page
    2. Frontmatter
    3. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part I. Introduction and Historical Perspective
    4. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part II. Tissue Sourcing
    5. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    6. Article: Part III. Immunoisolation and Encapsulation BIOARTIFICIAL ORGANS III: TISSUE SOURCING, IMMUNOISOLATION, AND CLINICAL TRIALS
    7. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    8. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IV. Biomaterial Purification and Compatability
    9. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part V. Islet and Bioartificial Pancreas
    10. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VI. Bioartificial Kidney and Liver
    11. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VII. Blood Substitutes and Endocrinology: Clinical Trials
    12. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VIII. Tissue Engineering
    13. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IX. Perspectives
    1. The Role of a Bioengineered Artificial Kidney in Renal Failure (pages 284–295)

      WILLIAM H. FISSELL, JASON KIMBALL, SHERRILL M. MACKAY, ANGELA FUNKE and H. DAVID HUMES

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03841.x

    2. Development of a Hybrid Liver Support System (pages 308–319)

      I. M. SAUER, N. OBERMEYER, D. KARDASSIS, T. THERUVATH and J. C. GERLACH

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03843.x

    3. Advances in Bioartificial Liver Assist Devices (pages 320–333)

      JOHN F. PATZER II

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03844.x

    4. Effect of Flow Configuration and Membrane Characteristics on Membrane Fouling in a Novel Multicoaxial Hollow-Fiber Bioartificial Liver (pages 334–343)

      JEFFREY M. MACDONALD, STEPHEN P. WOLFE, INDRAJIT ROY-CHOWDHURY, HIROSHI KUBOTA and LOLA M. REID

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03845.x

    5. Evaluating the Performance of a Hybrid Artificial Liver Support System With a Recoverable Hepatic Failure Rat Model (pages 344–349)

      HIROYUKI IJIMA, AYAKO NOGUCHI, TAKEYUKI KATSUNO, TSUTOMU ONO, KOHJI NAKAZAWA, KAZUMORI FUNATSU and KOEI KAWAKAMI

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03846.x

    6. Development of a Coculture Model of Encapsulated Cells (pages 350–361)

      LAURENCE CANAPLE, NATHALIE NURDIN, NELA ANGELOVA, DAVID HUNKELER and BÉATRICE DESVERGNE

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03847.x

  10. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VII. Blood Substitutes and Endocrinology: Clinical Trials

    1. Top of page
    2. Frontmatter
    3. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part I. Introduction and Historical Perspective
    4. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part II. Tissue Sourcing
    5. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    6. Article: Part III. Immunoisolation and Encapsulation BIOARTIFICIAL ORGANS III: TISSUE SOURCING, IMMUNOISOLATION, AND CLINICAL TRIALS
    7. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    8. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IV. Biomaterial Purification and Compatability
    9. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part V. Islet and Bioartificial Pancreas
    10. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VI. Bioartificial Kidney and Liver
    11. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VII. Blood Substitutes and Endocrinology: Clinical Trials
    12. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VIII. Tissue Engineering
    13. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IX. Perspectives
    1. β Cell Replacement for the Treatment of Diabetes (pages 373–387)

      JOSÉ OBERHOLZER, CHRISTIAN TOSO, FRÉDÉRIC RIS, PASCAL BUCHER, FRÉDÉRIC TRIPONEZ, ALP DEMIRAG, JINNING LOU and PHILIPPE MOREL

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03849.x

  11. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VIII. Tissue Engineering

    1. Top of page
    2. Frontmatter
    3. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part I. Introduction and Historical Perspective
    4. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part II. Tissue Sourcing
    5. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    6. Article: Part III. Immunoisolation and Encapsulation BIOARTIFICIAL ORGANS III: TISSUE SOURCING, IMMUNOISOLATION, AND CLINICAL TRIALS
    7. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    8. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IV. Biomaterial Purification and Compatability
    9. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part V. Islet and Bioartificial Pancreas
    10. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VI. Bioartificial Kidney and Liver
    11. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VII. Blood Substitutes and Endocrinology: Clinical Trials
    12. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VIII. Tissue Engineering
    13. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IX. Perspectives
    1. Hepatic Progenitors and Strategies for Liver Cell Therapies (pages 398–419)

      R. SUSICK, N. MOSS, H. KUBOTA, E. LECLUYSE, G. HAMILTON, T. LUNTZ, J. LUDLOW, J. FAIR, D. GERBER, K. BERGSTRAND, J. WHITE, A. BRUCE, O. DRURY, S. GUPTA and L. M. REID

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03851.x

    2. Formation of Sertoli Cell-Enriched Tissue Constructs Utilizing Simulated Microgravity Technology (pages 420–428)

      DON F. CAMERON, JOELLE J. HUSHEN, STANLEY J. NAZIAN, ALISON WILLING, SAM SAPORTA and PAUL R. SANBERG

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03852.x

    3. The Influence of Extracellular Matrix on the Generation of Vascularized, Engineered, Transplantable Tissue (pages 429–442)

      OLIVER C.S. CASSELL, WAYNE A. MORRISON, AURORA MESSINA, ANTHONY J. PENINGTON, ERIK W. THOMPSON, GEOFFREY W. STEVENS, JILSKA M. PERERA, HYNDA K. KLEINMAN, JOHN V. HURLEY, ROSALIND ROMEO and KENNETH R. KNIGHT

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03853.x

    4. An Approach to Constructing Three-Dimensional Tissue (pages 443–455)

      IN KAP KO and HIROO IWATA

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03854.x

  12. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IX. Perspectives

    1. Top of page
    2. Frontmatter
    3. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part I. Introduction and Historical Perspective
    4. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part II. Tissue Sourcing
    5. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    6. Article: Part III. Immunoisolation and Encapsulation BIOARTIFICIAL ORGANS III: TISSUE SOURCING, IMMUNOISOLATION, AND CLINICAL TRIALS
    7. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part III. Immunoisolation and Encapsulation
    8. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IV. Biomaterial Purification and Compatability
    9. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part V. Islet and Bioartificial Pancreas
    10. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VI. Bioartificial Kidney and Liver
    11. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VII. Blood Substitutes and Endocrinology: Clinical Trials
    12. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part VIII. Tissue Engineering
    13. Bioartificial Organs III: Tissue Sourcing, Immunoisolation, and Clinical Trialsa: Part IX. Perspectives
    1. Objectively Assessing Bioartificial Organs (pages 456–471)

      D. HUNKELER, A. REHOR, I. CEAUSOGLU, U. SCHULDT, L. CANAPLE, P. BERNARD, A. RENKEN, L. RINDISBACHER and N. ANGELOVA

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2001.tb03855.x

SEARCH

SEARCH BY CITATION